Stock info Merrimack Pharmaceuticals Inc | Filter  Basic-Info

Merrimack Pharmaceuticals Inc

Merrimack Pharmaceuticals Inc primarily operates in the pharmaceutical sector. Over the past 10 years the global pharmaceutical companies gained around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The past year gave good returns for Merrimack Pharmaceuticals Inc investors

Over the last 12 months (from December 2015 till December 2016), that were loss-making period for the investors in Merrimack Pharmaceuticals Inc, the stock lost around 35 percent. Merrimack Pharmaceuticals Inc' stock lost the past 5 years at around 0 percent. Merrimack Pharmaceuticals Inc's revenues between 2011 and 2015 were very fluctuating and moved between 48,92 million dollars and 89,26 million dollars. The net results between 2011 and 2015 were far from constant and fluctuated between -79,68 million dollars and -147,79 million dollars.

Over the past 5 years the American company paid out dividends.

Merrimack Pharmaceuticals Inc financed with a quite low debt position

At the end of 2015 the American company had a balance sheet of around 234,88 million dollars. 418,81 million dollars (178,31 percent of the total balance sheet) was financed by debt. As per the end of 2015 Merrimack Pharmaceuticals Inc's price/earnings-ratio equaled -8. So investors paid for 1 stock -8 times the earnings per share of 2015. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the American company's market capitalization equaled around 854,1 million dollars. At the end of 2015 the American company had around 111,36 million stocks listed.

At this page you find all Merrimack Pharmaceuticals Inc's financial reports. More information about Merrimack Pharmaceuticals Inc can be found it's website. .